FN1 and sarcoma: A key advantage is that ex vivo cord formation studies no longer required MatrigelTM (a complex mixture of murine laminin, type IV collagen and fibronectin extracellular matrix components derived from murine Engelbroth-Holm-Swarm (EHS) sarcomas) as an inductive substrate.